Protective role of rosmarinic acid against radiation-induced dermatitis: focus on oxidative stress and inflammation Authors: Betül Zehra Karip, Esra Çikler, Hakan Beyaztaş, Eray Metin Güler, Serhat Aras, Fevzi Esen Published: 2026 ABSTRACT AbstractBackgroundThis study investigated the potential protective role of rosmarinic acid (RA) against oxidative stress, inflammation, and fibrosis induced by ionizing radiation in an experimental rat model.MethodsA total of 42 male Sprague–Dawley rats were randomly divided into seven groups (n = 6): G0, G1(14), G1(28), G2(14), G2(28), G3(14), and G3(28). While the G1 groups were exposed to radiation without treatment, the G2 groups received intraperitoneal saline, and the G3 groups were administered 20 mg/kg RA intraperitoneally. Skin tissue samples were collected on days 14 and 28 for histopathological, immunofluorescence, and biochemical analyses. Statistical evaluation was performed via SPSS software.ResultsHistological evaluation revealed intact skin morphology in the G0 group, whereas the G1 and G2 groups exhibited structural disorganization, epidermal and dermal loss, and hyperplasia. Mast cell infiltration and inflammatory activity were significantly increased, accompanied by reduced vascularization. In contrast, the morphological damage in the G3 group was ameliorated. Immunofluorescence analysis revealed elevated TGFβ-1 and 8-OHdG expression in G1 and G2, which was markedly reduced in G3. Similarly, the levels of biochemical markers of oxidative stress and inflammation were greater in the G1 and G2 groups but lower in the RA-treated groups.ConclusionsRosmarinic acid administration mitigated radiation-induced oxidative damage, inflammatory responses, and fibrotic changes in skin tissue. These findings suggest that RA exerts protective effects against radiation-induced skin injury through modulation of oxidative stress and inflammation in this experimental model.Keywords: Oxidative stress, Radiotherapy, Rosmarinic acid, Skin Introduction Radiotherapy (RT) is one of the most prevalent treatment methods for cancer. However, this treatment has the potential to damage both the tumor and the surrounding healthy tissue. The skin tissue with which RT first comes into contact and is most affected is anatomically located on the body surface [1]. Consequently, the skin is highly sensitive to the acute and chronic effects of ionizing radiation. As demonstrated in the extant literature, cutaneous reactions of varying severity have been reported in a minimum of 90% of patients undergoing RT [2]. These reactions can result in radiodermatitis, which is a progressive and often irreversible process that can develop during or after treatment [3]. Radiodermatitis: Although the condition initially presents with symptoms such as erythema, edema, and desquamation, it can progress to a chronic condition with permanent damage, including fibrosis, atrophy, and telangiectasia, over months [4]. The biological effects of RT are manifested primarily through DNA damage and increased production of reactive oxygen species (ROS). This process leads to the disruption of the cell cycle and the initiation of the inflammatory response [5, 6]. Ionizing radiation has a detrimental effect on DNA, resulting in direct damage to it. In addition, ionizing radiation has been observed to cause the ionization of water molecules, thereby producing short-lived free radicals. Oxidative stress, which is triggered by an increase in free radicals, has been demonstrated to damage both cellular structures and microvascular integrity [7]. Impaired vascularization can lead to the development of hypoxia and fibrosis within the tissue [8]. Ionizing radiation has a detrimental effect on DNA, resulting in direct damage to it. In addition, ionizing radiation has been observed to cause the ionization of water molecules, thereby producing short-lived free radicals. Oxidative stress, which is triggered by an increase in free radicals, has been demonstrated to damage both cellular structures and microvascular integrity [9]. Impaired vascularization can lead to the development of hypoxia and fibrosis within the tissue [10]. Following tissue injury, mast cell activation and macrophage-derived cytokines such as tumor necrosis factor (TNF-α), interleukin-6 (IL-6) and interleukin-1beta (IL-1β) initiate the inflammatory response, while increased ROS further amplify this cascade [11]. Mast cells also play an essential role in this process; the mediators they release through degranulation contribute to the chronicity of the microenvironment by increasing both inflammation and ROS production [11]. Elevated oxidative stress is associated with increased levels of the DNA damage marker 8-hydroxy-2′-deoxyguanosine (8-OHdG) and can be reflected by alterations in total oxidant status (TOS), total antioxidant status (TAS), and the oxidative stress index (OSI) [12]. Under radiation conditions, excessive ROS production and cytokine activation stimulate transforming growth factor beta-1 (TGF-β1)–mediated Smad signaling, promoting fibroblast activation and extracellular matrix deposition, thereby disrupting the normal wound healing cascade and favoring fibrosis [10]. It has been demonstrated that endogenous antioxidant systems are inadequate in counteracting the oxidative stress induced by RT. This phenomenon enables the progression of damage [13]. Consequently, the replacement of potent antioxidants, particularly those of plant origin, remains a significant concern [14]. Rosmarinic acid (RA), a water-soluble polyphenolic compound derived from rosemary, is notable for its antioxidant, anti-inflammatory, and antifibrotic properties [15–17]. Previous experimental studies have reported that rosmarinic acid exerts protective effects against cellular damage induced by ionizing and ultraviolet radiation [18]. The effects of RA on skin diseases have been investigated in various experimental models. In models of psoriasis and dermatitis, RA has been reported to reduce proinflammatory cytokines, suppress inflammation, and limit oxidative DNA damage. Herath et al. (2024) demonstrated that RA offers a protective effect against oxidative stress in HaCaT keratinocytes, a type of skin cell, by decreasing DNA damage [19]. These effects are hypothesised to be associated with the antioxidant and anti-inflammatory properties of RA [20–22]. Beyond the skin, RA has also demonstrated efficacy in models of systemic or organ-specific damage. It has been demonstrated through experimental studies that RA exerts a suppressive effect on inflammation and a restrictive influence on fibrotic processes [13]. In our study, we investigated the potential protective effects of RA at the systemic level against radiation-induced dermatitis in healthy skin tissue exposed to X-rays via an experimental model. Material methods Animals The experimental protocol in its entirety was approved by the Istanbul Medipol University Animal Experiments Local Ethics Committee (Med-HADYEK; Approval No: 27, Date: April 21, 2023). Forty-two male Sprague–Dawley rats, aged 6–8 weeks and weighing 250–300 g, were obtained from the Istanbul Medipol University Laboratory Animal Application and Research Centre. The animals were housed in standard cages in an environment with a temperature of 22–23 °C, 60% humidity, and a 12-h light/dark cycle. Food and water were provided ad libitum. Preparation of rosmarinic acid Rosmarinic acid (Ambeed, CAS:796,919) was prepared fresh daily; it was dissolved in a 0.9% saline solution at a dose of 20 mg/kg and administered intraperitoneally. The dose calculation was based on the weighed body weight of each experimental animal [23, 24]. Radiotherapy procedures All the rats except those in the control group were anesthetized via the intraperitoneal administration of ketamine (75 mg/kg) and xylazine (5 mg/kg). The depth of anesthesia was confirmed by the absence of reflexes, including the toe pinch response, before the commencement of any intervention. The flexion regions of the left hind legs of all the rats were shaved one day before radiotherapy. During irradiation, the animals were positioned supine, and only the abdomen–hind limb junction (inguinal/flexural region) was exposed [25, 26]. The supine positioning was preferred to minimise the risk of secondary trauma in case of skin injury and to preserve experimental continuity, while this flexural region was selected for its anatomical and clinical relevance [27–29]. In this study, total body irradiation was not applied; only localized skin areas were targeted. To ensure selective irradiation, the rest of the body was shielded with lead blocks, and the radiation beam was confined to the target area via the Varian Trilogy linear accelerator's collimation system. This procedure effectively confines the beam to the target area, thereby minimizing radiation exposure to nontargeted tissues and organs. A single dose of radiotherapy at 20 Gy was administered via a 6 MeV electron beam from a Varian Trilogy linear accelerator located in the radiotherapy unit at Haydarpaşa Numune Training and Research Hospital, Health Sciences University. A single 20 Gy dose is a common inducer of acute and chronic skin damage in experimental radiation-induced dermatitis models, as evidenced by previous studies [30, 31]. The radiation skin-source distance (SSD) was set at 100 cm. Irradiation areas measuring 3 × 3 cm2 were defined as areas not protected by lead plates, and bolus material was placed to ensure dose homogeneity. Before the initiation of radiotherapy, dose calibration of the apparatus was performed to ensure a dose efficiency of 1 MU = 1 cGy. For the 6 MeV electron beams, the maximum dose point (Dmax) was determined at a depth of 1.6 cm from the skin surface, and subsequent irradiation procedures were conducted accordingly [27, 32, 33]. After irradiation, the animals were continuously monitored until they had fully recovered from the anesthetic, which typically took 15–20 min. The administration of saline (G2) and rosmarinic acid (G3) was initiated on the day following radiotherapy to evaluate their effects on established radiation-induced tissue injury. The substances were administered intraperitoneally once daily for a period of either 14 or 28 consecutive days. Experimental groups The present study was conceived with the objective of evaluating the protective effects of rosmarinic acid (RA) in relation to radiation-induced skin injury. Accordingly, the experimental groups were structured to assess radiation exposure with and without RA treatment. Given the emphasis on radiation-induced alterations and the 3R principles to minimise unnecessary animal use, a separate RA-only control group was not included [24]. The saline-treated group was incorporated as an injection control to account for potential procedural effects and to eliminate fluid administration as a confounding factor. The 14- and 28-day time points were selected to reflect the acute inflammatory response and the subsequent early fibrotic remodeling phase after radiation exposure [29, 30]. Following the power analysis, a total of 42 rats were randomized into seven groups of six: G0 (control): No irradiation; sample on day 28 G0 (control): No irradiation; sample on day 28 G1 (14): Single-dose irradiation; sample on day 14 G1 (14): Single-dose irradiation; sample on day 14 G1 (28): Single dose of irradiation; sample on day 28 G1 (28): Single dose of irradiation; sample on day 28 G2 (14): Irradiation and 0.9% saline were administered; samples were collected on day 14 G2 (14): Irradiation and 0.9% saline were administered; samples were collected on day 14 G2 (28): Irradiation and 0.9% saline were administered; samples were collected on day 28 G2 (28): Irradiation and 0.9% saline were administered; samples were collected on day 28 G3 (14): Irradiation + 20 mg/kg RA dissolved in 0.9% saline applied; group sampled on day 14 G3 (14): Irradiation + 20 mg/kg RA dissolved in 0.9% saline applied; group sampled on day 14 G3 (28): Irradiation + 20 mg/kg of RA dissolved in 0.9% saline was applied to this group, which was sampled on day 28 G3 (28): Irradiation + 20 mg/kg of RA dissolved in 0.9% saline was applied to this group, which was sampled on day 28 Histopathological examination Twenty-four hours after the final administration, the animals were deeply anesthetized. Under anaesthesia, skin tissue samples were harvested from the exact irradiated field (3 × 3 cm2 in the abdomen–hind limb junction area), and a portion of the collected tissue was fixed in 10% neutral buffered formalin (NBF) for 72 h. Subsequently, blood samples were collected via cardiac puncture, and the animals were finally euthanized by decapitation. The remaining tissue samples were stored at −80 °C for biochemical analysis. The tissues were dehydrated in a series of increasing alcohol concentrations, cleared in xylene, and embedded in paraffin wax. Slides containing five µm-thick sections were stained with hematoxylin and eosin (H-E), Masson's trichrome, and toluidine blue [34–36]. The sections were deparaffinized in three different xylene baths, after which they were rehydrated in a series of decreasing alcohol solutions. Following hematoxylin staining, the sections were washed with tap water and counterstained with eosin. Following dehydration, the sections were cleared with xylene and sealed with Entellan. Morphometric analysis involved measuring the thickness of the epidermis and dermis in 10 different areas of sections taken from each subject [27, 37]. Inflammatory cell infiltration and capillary count in the papillary dermis were evaluated via a semi-quantitative scoring (SQS) method [38]. Eighteen micrographs, which were randomly selected from Masson's trichrome-stained sections, were analyzed at 200 × magnification [37, 39]. Collagen density was quantified using ImageJ software by applying a color threshold to Masson’s trichrome–stained sections. Mast cells were counted and classified as either granulated or degranulated according to their activity [40]. Immunofluorescence examination The sections were deparaffinized in xylene and rehydrated via a series of increasingly dilute alcohol solutions. To retrieve the antigens, the sections were heated in a microwave in citrate buffer and then incubated overnight with primary antibodies against TGF-β1 and 8-OHdG. After incubation with an Alexa Fluor 488-conjugated secondary antibody and DAPI, the sections were blocked. This was performed with a PBS-glycerol-containing sealing medium. The sections were then stored at + 4 °C in the dark. Imaging was performed using a Zeiss Axio Vert.A1 fluorescence microscope. Micrographs obtained from twenty randomly selected areas in three different sections per animal were quantitatively analyzed using ImageJ software (NIH, USA). Mean fluorescence intensity (MFI) and integrated density values were calculated for TGF-β1 and 8-OHdG staining after background subtraction. All image analyses were performed by an observer blinded to the experimental groups to minimize potential bias [41]. Biochemical analyses Protein assay The tissue samples were homogenized in PBS, after which the supernatant was obtained via centrifugation. The total protein content was measured via a Coomassie Plus protein assay kit, with the absorbance value measured at 595 nm via a BioTek Synergy™ HTX device. Total antioxidant and oxidant status (TAS-TOS) TAS and TOS levels were measured via commercial ELISA kits. The results are expressed as µmol Trolox equivalent/L and µmol H₂O₂ equivalent/L, respectively. The OSI value was calculated by dividing TOS by TAS [42]. Measurement of cytokine levels IL-1β, IL-6, and TNF-α levels were measured via BTLab ELISA kits, and standard curves were generated for each analysis. The absorbance was measured at 450 nm. The obtained data are expressed in ng/mL and normalized were normalized to total protein levels [43]. Statistical analyses Data distribution was evaluated via Shapiro–Wilk test. Nonparametric tests were used due to the failure to meet the standard distribution assumption and violation of variance homogeneity, as determined by Levene test. For inter-group comparisons (comparing G0, G1, G2, and G3 at each time point), Kruskal–Wallis H test was performed, followed by Dunn post hoc test for pairwise comparisons. Statistically significant differences between groups for a specific variable are indicated by different subscript letters within the same column. For intra-group comparisons (comparing Day 14 vs. Day 28 within each specific group), Mann–Whitney U test was utilized. The resulting significance levels for these longitudinal changes are presented in the final “p” column of the tables. Analyses were performed via SPSS 27.0. Graphical representations were created via Prism 9.2.0. A significance level of p < 0.05 was set. Results Light microscopic findings Hematoxylin–Eosin (H-E) staining H&E-stained sections revealed the following findings in the G0 group: the integrity of the epidermis and dermis was preserved, inflammatory cell infiltration was minimal, and typical vascular structures were present (Fig. 2A). In the G1 (14) and G2 (14) groups that received radiotherapy, areas of hypoplasia were observed alongside areas of hyperplasia in the epidermis (Fig. 1A and B). Similarly, epidermal thickening and atrophic regions were observed in the G1 (28) and G2 (28) groups (Fig. 1B and 1 C). Significant infiltration of inflammatory cells was detected in the dermis (Fig. 1A, B) (Fig. 2B, C). Continued damage to vascularization was observed. Breaks and edema were detected between dermal collagen fibers in all the G1 and G2 groups (Fig. 1A, B) (Fig. 2B, C). In the G3 (14) and G3 (28) groups treated with rosmarinic acid, normal morphology and arrangement of the cells in the epidermal tissue were observed (Fig. 1C), (Fig. 2D). A significant reduction in inflammatory cell infiltration and edema in the dermis was observed. The vascular structure was more regular than that in groups 1 and 2 (Fig. 1C) and (Fig. 2D). Representative histological findings of the 28-day experimental groups. A–C H&E staining showing epidermal thickness variations (thin arrow, thick arrow), inflammatory cell infiltration (black arrowhead), dermal intercellular edema (double arrowhead); magnification × 100; scale bar: 100 μm. D–F Masson’s trichrome staining demonstrating collagen fibers (star); magnification × 200; scale bar: 50 μm. G–J Toluidine blue staining showing dermal mast cells (blue arrowhead); magnification × 400; scale bar: 25 μm Representative histological findings of the 14-day experimental groups. A–C Hematoxylin and eosin (H&E) staining showing epidermal thickness variations (thin arrow, thick arrow), inflammatory cell infiltration (black arrowhead), and dermal intercellular edema (double arrowhead); magnification × 100; scale bar: 100 μm. D–F Masson’s trichrome staining demonstrating collagen fibers (star); magnification × 200; scale bar: 50 μm. G–J Toluidine blue staining showing dermal mast cells (blue arrowhead); magnification × 400; scale bar: 25 μm Masson's trichrome staining In the sections stained with Masson's trichrome, a regular and homogeneous distribution of dermal collagen fibers was observed in the G0 group (Fig. 1E). In the G1 (14) and G2 (14) groups, breaks and concentrations in the collagen fibers, as well as an increase in fibrotic areas, were observed (Fig. 2D, E). In the G1 (28) and G2 (28) groups, breaks and regional concentrations of dermal collagen fibers persisted (Fig. 1F, G). In the G3 (14) and G3 (28) groups treated with rosmarinic acid, the distribution of collagen became more homogeneous, and the fibers exhibited a normal morphology (Fig. 2F), (Fig. 1H). Toluidine blue staining Toluidine blue staining revealed few mast cells with a granular morphology in the G0 group (Fig. 1J). An increase in the number of mast cells, as well as their activation in a degranulated form, was observed in the G1 (14) and G2 (14) groups (Fig. 2G, H). These findings persisted in the G1 (28) and G2 (28) groups, indicating that the inflammatory response continued. Mast cells were predominantly observed in a degranulated form (Fig. 1K, L). In the G3 (14) and G3 (28) groups treated with rosmarinic acid, the granular structure of the mast cells was preserved, and degranulation was reduced (Fig. 2J, M). Morphometry Morphometric analyses of histological sections were used to quantitatively evaluate the tissue changes associated with radiotherapy, as well as the effects of RA replacement on these changes. Statistical comparisons were made of epidermal and dermal thickness measurements, dermal collagen density, inflammatory cell infiltration, vascularization density, and mast cell counts. Epidermal and dermal thicknesses were significantly increased in irradiated groups (G1 and G2) at both day 14 and day 28 compared with controls (p < 0.01; p < 0.001) (Fig. 3), reflecting radiation-associated tissue swelling and structural alteration. Thickness values were generally higher at day 14 than at day 28 in irradiated groups. Specifically, epidermal thickness in G1 (14) and G2 (14) was significantly greater than in their respective day 28 counterparts (p < 0.001), while dermal thickness showed a similar trend but did not consistently reach statistical significance (Table 1). RA treatment significantly reduced both epidermal and dermal thickness at day 14 compared with G1 (14) and G2 (14) (p < 0.001) (Fig. 3). At day 28, thickness values in the G3 group were significantly lower than in G1 (28) (p < 0.001; p < 0.01), whereas the reduction compared with G2 (28) did not reach statistical significance. Within the RA-treated groups, epidermal and dermal thicknesses were lower at day 14 than at day 28 (p < 0.001; p < 0.01) (Table 1). Histopathological and morphometric analyses of experimental groups on days 14 and 28: (a) epidermal thickness, (b) dermal thickness, (c) dermal collagen density, (d) inflammatory cell infiltration, and (e) tissue vascularization. *p < 0.05; **p < 0.01; ***p < 0.001 Table 1Comparative analyses of histological and tissue parameters among the experimental groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same groupGroupVariableDayGroupDay 14Day 28MeanS.EMeanS.EG0Epidermal Thickness(µm)29.14a1.2029.14a1.20-Dermal Thickness(µm)672.64a16.71672.64a16.71-Collagen Density(%)39,070.33a2095.6739,070.33a2095.67-Inflammation(SQS).17a.09.17a.09-Vascularization(vessels/mm2)5.33a.245.33a.24-G1Epidermal Thickness(µm)100.73b3.5480.81b3.67.000Dermal Thickness(µm)1241.17b31.491060.25b33.03.000Collagen Density(%)62,758.50b1936.9768,241.50b5724.16.109Inflammation(SQS)2.17b.121.89b.14.420Vascularization(vessels/mm2)2.44b.252.72b.35.477G2Epidermal Thickness(µm)101.29b3.0180.24b3.27.000Dermal Thickness(µm)1115.42b17.171095.31b27.27.551Collagen Density(%)61,317.50b2313.3665,724.50b,c2641.00.423Inflammation(SQS)1.72b,c.161.83b.15.624Vascularization(vessels/mm2)2.00b.212.94b.19.002G3Epidermal Thickness(µm)60.11c3.0648.00c2.59.004Dermal Thickness(µm)849.04c23.73707.79a15.41.000Collagen Density(%)48,197.50a2175.3948,851.67a,c1067.82.522Inflammation(SQS)1.22c.101.06c.17.389Vascularization(vessels/mm2)4.33a.244.33a.33.815 Comparative analyses of histological and tissue parameters among the experimental groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same group Dermal collagen density was significantly increased in all irradiated groups (G1 and G2) at both day 14 and day 28 compared with controls (p < 0.001) (Fig. 3), indicating radiation-induced extracellular matrix accumulation. Although collagen density tended to be higher at day 28 than at day 14 in irradiated groups, this increase did not reach statistical significance (Table 1). RA treatment significantly reduced collagen density at day 14 compared with G1 (14) and G2 (14) (p < 0.05). At day 28, collagen density in the G3 group was significantly lower than in G1 (28) (p < 0.05), however did not differ significantly from G2 (28) (Fig. 3). No significant differences were observed between day 14 and day 28 in the RA-treated groups (Table 1). Inflammatory cell infiltration was significantly increased in all irradiated groups (G1 and G2) at both day 14 and day 28 compared with controls (p < 0.01) (Fig. 3), confirming a sustained inflammatory response following radiation exposure. RA treatment significantly reduced inflammatory cell infiltration at both time points. Specifically, the G3 (14) group exhibited lower infiltration compared with G1 (14) and G2 (14) (p < 0.05), and similar reductions were observed at day 28 (p < 0.01; p < 0.001). (Fig. 3). No significant differences were observed between day 14 and day 28 within irradiated groups (Table 1), indicating persistence of inflammatory infiltration over time. In contrast, inflammatory levels in RA-treated groups remained comparable between the two time points (Table 1). Vascularization was significantly reduced in all irradiated groups (G1 and G2) at both day 14 and day 28 compared with controls (p < 0.001) (Fig. 3), indicating radiation-associated microvascular impairment. Vascular density was relatively higher at day 14 than at day 28 within irradiated groups (Table 1), suggesting progressive vascular compromise over time. RA treatment significantly improved vascularization at both time points. The G3 (14) group exhibited higher vascular density compared with G1 (14) and G2 (14) (p < 0.05), and similar improvements were observed at day 28, where vascularization in G3 (28) was significantly greater than in G1 (28) and G2 (28) (p < 0.01; p < 0.001) (Fig. 3). No significant temporal differences were observed within the RA-treated groups (Table 1). Irradiated groups demonstrated increased numbers of both granulated and degranulated mast cells at day 14 compared with controls; however, the increase was statistically significant only for degranulated mast cells (p < 0.01), (Fig. 4). These findings suggest persistence of mast cell activation beyond the acute phase, potentially contributing to ongoing inflammatory and remodeling processes. Compared with G3 (28), both irradiated groups exhibited significantly higher mast cell counts (p < 0.01; p < 0.001), indicating a sustained modulatory effect of RA (Fig. 4). Comparison of granulated and degranulated mast cell counts between experimental groups on (a) day 14 and (b) day 28. Statistical significance is indicated as *p < 0.05; **p < 0.01; ***p < 0.001 At day 28, mast cell numbers remained elevated in irradiated groups. In G1 (28), both granulated and degranulated mast cells were significantly increased, whereas in G2 (28), only degranulated mast cells showed a significant elevation (p < 0.01), (Fig. 4). These findings suggest persistence of mast cell activation beyond the acute phase. Compared with G3 (28), both irradiated groups exhibited significantly higher mast cell counts (p < 0.01; p < 0.001), indicating a sustained modulatory effect of RA (p < 0.01; p < 0.001), (Fig. 4). Temporal comparisons revealed that degranulated mast cells were significantly higher in G1 (14) than in G1 (28) (p < 0.05), consistent with peak inflammatory activation at day 14. Conversely, degranulated mast cells increased from day 14 to day 28 in the saline-treated group (p < 0.01), suggesting prolonged inflammatory activity in the absence of RA. In the RA-treated groups, granulated mast cells were higher at day 28 than at day 14, while degranulated mast cells tended to decrease, indicating partial stabilization of mast cell activity over time (Table 2). Table 2Comparison of granulated and degranulated mast cell counts among groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same groupGroupVariableDay 14Day 28pMeanS.EMeanS.EG0Granulated.15a,b.05.15a.15a,b-Degranulated.33a.06.33a.33a-G1Granulated.23a.06.01b.23a.000Degranulated1.92b.122.3b1.92b.016G2Granulated.05b.03.10a,b.05b.113Degranulated1.80b.122.40b1.80b.001G3Granulated.5c.09.25a.5c.004Degranulated.57a.08.62a.57a.089 Comparison of granulated and degranulated mast cell counts among groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same group Immunofluorescence findings The 8-OHdG and TGF-β1 antigens exhibited minimal labeling in the control group when evaluated by immunofluorescence staining. Increased nuclear staining for 8-OHdG was observed in the G1 (14) and G2 (14) groups. Labeling was found to be preserved in dead keratinocytes in the stratum corneum layer (Fig. 6). TGF-β1 labeling was observed in the cytoplasm of epidermal and dermal cells. It was found to show intense labeling (Fig. 5). Labeling in the G1 (28) and G2 (28) groups continued similarly, maintaining its intensity (Figs. 5 and 6). In the G3 (14) and G3 (28) groups treated with rosmarinic acid, decreases in both 8-OHdG- and TGF-β1-positive staining intensities were detected (Figs. 5 and 6). 8-OHdG immunofluorescence staining in experimental groups. Green: 8-OHdG–positive cells; blue: DAPI nuclear counterstaining. Magnification × 200; scale bar: 50 μm TGF-β1 immunofluorescence staining in experimental groups. Green: TGF-β1–positive cells; blue: DAPI nuclear counterstaining. Magnification × 200; scale bar: 50 μm Anti-TGF-β1 immunofluorescence evaluations TGF-β1 immunofluorescence intensity was significantly increased in irradiated groups (G1 and G2) at both day 14 and day 28 compared with controls (p < 0.001) (Fig. 7), indicating activation of profibrotic signaling following radiation exposure. At day 14, staining intensity in G1 and G2 was significantly higher than in the RA-treated group (p < 0.001). Similar findings were observed at day 28, where TGF-β1 labeling in G3 was significantly lower than in G1 and G2 (p < 0.05; p < 0.01). Comparison of immunofluorescence labeling between experimental groups for (a) anti-TGFβ−1 and (b) anti-8-OHdG. Statistical significance is indicated as *p < 0.05; **p < 0.01; ***p < 0.001 No significant differences were detected between day 14 and day 28 within the same treatment groups (Table 3), suggesting persistence of TGF-β1 expression over time. Table 3Comparison of mean and standard error data of anti-TGFß−1 and anti-8-OHdG immunofluorescence labeling in experimental groups between days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same groupGroupVariableDaypDay 14Day 28MeanStd. ErrorMeanStd. ErrorG0TGFß−11191.06a22.971191.06a22.97-8-OHdG1103.78a12.811103.78a12.81-G1TGFß−11985.61b111.001936.06b137.37.1328-OHdG1629.61b62.802014.06b121.49.008G2TGFß−12084.94b121.872134.61b84.41.7678-OHdG1908.67b88.902056.22b121.54.293G3TGFß−11407.22a56.751490.39a36.02.1818-OHdG1352.11c34.331541.72c67.00.047 Comparison of mean and standard error data of anti-TGFß−1 and anti-8-OHdG immunofluorescence labeling in experimental groups between days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same group Anti-8-OHDG immunofluorescence evaluations 8-OHdG immunofluorescence intensity was markedly elevated in irradiated groups at both time points compared with controls (p < 0.001) (Fig. 7), reflecting radiation-induced oxidative DNA damage. At day 14, G1 and G2 groups demonstrated significantly higher labeling than the RA-treated group (p < 0.05; p < 0.001). A similar pattern was observed at day 28, where labeling intensity in G3 was significantly lower than in G1 and G2 (p < 0.05). Temporal comparisons revealed higher 8-OHdG labeling at day 28 than at day 14 in G1 and G3 (p < 0.01; p < 0.05), indicating sustained oxidative DNA damage in the later phase. In contrast, the increase observed in G2 between day 14 and day 28 did not reach statistical significance (Table 3). Biochemical findings TAS-TOS-OSI analyses Total antioxidant status (TAS) was highest in the control group and significantly decreased in both irradiated groups at day 14 (G1 and G2; p < 0.001), indicating an early impairment of antioxidant defense following radiation exposure (Fig. 8). Similarly, this decrease was significant in the G1 (28) and G2 (28) groups (p < 0.05), (p < 0.01), (Fig. 8). While TAS did not significantly differ between G1 (14) and G1 (28), the G2 (14) group exhibited significantly lower TAS levels than G2 (28) (p < 0.05), suggesting a gradual compensatory response over time (Table 4). RA treatment partially restored TAS levels at day 14 compared with G1 (14) (p < 0.01), although this improvement did not reach significance compared with the saline-treated group (Fig. 8). Similarly, the increase in the G3 (28) group was also not significant (Fig. 8), (Table 4). Comparison of tissue biochemical markers between experimental groups: (a) TAS levels on day 14 and 28, (b) TOS levels on days 14 and 28, and (c) OSI levels on days 14 and 28. Statistical significance is indicated as *p < 0.05; **p < 0.01; ***p < 0.001 Table 4Average and statistically significant data for tissue total antioxidant status, total oxidant status, and oxidative stress index values for the groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same groupGroupVariableDayGroupDay 14Day 28MeanS.EMeanS.EG0TOS4.51a.274.51a.27-TAS1.13a.061.13a.06-OSI3.98a.093.98a.09-G1TOS15.17b.3812.99b.54.015TAS.63b.02.77b.08.065OSI24.31b.8418.36b2.75.065G2TOS14.68b.2112.86b.54.026TAS.67b.02.81b.04.026OSI22.16b1.0116.02b.78.002G3TOS9.47a,b.628.23a,b.68.240TAS.98a,c.031.03a,b.05.699OSI9.79a,b.908.10a,b.78.093 Average and statistically significant data for tissue total antioxidant status, total oxidant status, and oxidative stress index values for the groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same group Total oxidant status (TOS) was significantly elevated in irradiated groups at both time points, with a more pronounced increase at day 14 (p < 0.001; p < 0.01), reflecting acute oxidative stress following RT (Fig. 8). Although TOS levels remained significantly elevated at day 28 (p < 0.01), they were lower than those observed at day 14 (p < 0.05), indicating a relative decline in acute oxidative burden over time (Table 4). RA-treated groups showed a trend toward reduced TOS levels at both time points; however, these reductions were not statistically significant compared with irradiated controls (Fig. 8). The TOS level in the G3 (14) group was not significantly greater than that in the G3 (28) group (Table 4). Consistent with TAS and TOS findings, oxidative stress index (OSI) values were markedly increased in irradiated groups, particularly at day 14 (p < 0.001; p < 0.01), supporting the presence of severe early oxidative injury and impaired antioxidant defense following radiation exposure (Fig. 8). Although OSI levels remained elevated at day 28, they were lower than those recorded on day 14, suggesting partial adaptation of antioxidant mechanisms (Table 4). RA administration was associated with a modest reduction in OSI at both time points, though the differences did not reach statistical significance (Fig. 8). The OSİ of the G3 (14) group was not significantly greater than that of the G3 (28) group (Table 4). ELISA results (IL-1β, IL-6, and TNF-α) The proinflammatory cytokines IL-1β, IL-6, and TNF-α were significantly elevated in irradiated groups (G1 and G2) at both day 14 and day 28 compared with controls (p < 0.01; p < 0.001) (Fig. 9), confirming a sustained inflammatory response following radiation exposure. Cytokine levels were higher at day 14 than at day 28 within irradiated groups (Table 5), indicating that inflammatory activity was more pronounced during the early phase after RT. Comparison of tissue cytokine levels between experimental groups: (a) TNF-α, (b) IL-1β and (c) IL-6 on days 14 and 28. Statistical significance is indicated as *p < 0.05; **p < 0.01; ***p < 0.001 Table 5Average and statistically significant data for tissue TNF-α, IL-1β, and IL-6 values in groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same groupGroupVariableDaypDay 14Day 28MeanS.EMeanS.EG0TNF- α134.26a5.37134.26a5.37-IL-1ß18.67a2.2518.67a2.25-IL-66.90a.886.90a.88-G1TNF- α523.21b3.71495.25b5.17.002IL-1ß68.14b4.2854.43b3.26.026IL-627.45b1.6026.24c1.72.485G2TNF- α519.94b4.31492.34b6.29.004IL-1ß66.26b4.1851.65b2.45.041IL-624.28b.7521.87b,c.68.026G3TNF- α331.30a,b4.98308.71a,b3.09.009IL-1ß32.94a,b1.6525.64a,b.90.002IL-615.84a,b1.8412.16a,c.71.180 Average and statistically significant data for tissue TNF-α, IL-1β, and IL-6 values in groups on days 14 and 28. Different subscript letters within the same column for a specific variable indicate a statistically significant difference (p < 0.05) between the groups. P values represent comparisons between Day 14 and Day 28 within the same group RA treatment did not significantly alter cytokine levels at day 14 compared with irradiated groups. However, at day 28, cytokine levels in the G3 group were lower than in G1 (28) and G2 (28), with a statistically significant reduction observed for IL-6 (p < 0.05) (Fig. 9). These findings suggest a partial attenuation of sustained inflammatory signaling in the later phase following RA administration. Discussion Radiotherapy is an indispensable part of modern oncological treatments. Despite its ability to promote survival, this method can result in adverse effects on healthy tissues [44]. The effects under discussion are most commonly observed in skin tissue, which, owing to its anatomical location on the surface of the body and its high rate of mitotic activity, is particularly susceptible to the effects of UV radiation. As demonstrated in the extant literature, a range of morphological and biochemical alterations in skin tissue are evident in both the acute and chronic phases following RT [5]. The initial phase of inflammation, known as the acute phase, is characterized by symptoms such as erythema, desquamation, and edema. However, fibrotic changes that emerge weeks to months after RT administration and are characterized by permanent tissue damage are a result of the chronicity of this inflammation [4, 5]. Ionizing radiation, a critical component of radiotherapy, affects cells through two principal mechanisms: direct damage to DNA and indirect damage via the formation of reactive oxygen species (ROS) from the ionization of water molecules [45]. The damage caused inside cells leads to an increase in oxidative stress. Oxidative stress has been demonstrated to trigger an inflammatory response and impede tissue regeneration [46]. This condition leads to the development of fibrosis, characterized by edema, inflammatory cell infiltration, and collagen fiber accumulation, particularly in the dermal region [27]. In our study, it was determined that epidermal and dermal thicknesses were altered over time in groups that were observed for 14 and 28 days following RT. In particular, epidermal atrophy and loss of epithelial hair follicles were observed in the 28-day group. These changes are hypothesized to be related to increased oxidative stress and decreased tissue regeneration capacity [27]. In the groups that underwent RT, cellular irregularities were observed in the epidermal layer, whereas edema, inflammatory cell infiltration, and irregularly arranged collagen fibers were detected in the dermis. The present study revealed that collagen density scores were elevated in both the G1 (28) and G2 (28) groups. In particular, fibrotic formation increased and became more pronounced after 28 days of follow-up. Subsequent evaluation of dermal thickness measurements following RT revealed an increase attributable to edema and inflammation in the G1 (14) and G2 (14) groups. However, by day 28, these acute findings had abated, and instead, a dense and organized fibrotic tissue structure with concentrated collagen fibers had developed. This finding indicates that the observed decrease in dermal thickness on day 28 is associated with fibrotic changes related to the remodeling of connective tissue. Fibrotic tissue and microvascular structural impairments resulting from chronic inflammation are factors that sustain hypoxia and oxidative stress in tissues [47]. Sustained hypoxia and microvascular compromise further enhance ROS production, thereby perpetuating oxidative stress and promoting a self-amplifying cycle of tissue injury and remodeling. The level of oxidative stress was supported by biomarkers such as 8-OHdG, TOS, TAS, and OSI. In the G1 (14) and G1 (28) groups treated with RT, the 8-OHdG labeling level was significantly greater than that in the control group, and this increase was more pronounced on day 28 [48]. The gradual increase in 8-OHdG density in the epidermis in the G1 (28) group indicates that disruptions in the epithelial cycle cause morphological damage. Compared with those in the control group, the levels of TOS and OSI increased in the G1 and G2 groups treated with RT, whereas the TAS decreased. These findings collectively indicate a persistent imbalance between oxidant production and antioxidant defense mechanisms following radiation exposure. The detection of elevated levels of TOS and OSI in the G1 (14) and G2 (14) groups indicated that oxidative stress increased both directly and indirectly. In contrast, TOS and OSI levels were lower in the G1 (28) and G2 (28) groups than in the 14-day follow-up groups. The observation that these levels remained elevated in comparison with those in the control group indicates the persistence of an indirect increase associated with DNA damage. This finding suggests that the damage to the tissue is ongoing [49]. The Nrf2/HO-1 signaling pathway is a critical cellular defense mechanism against ROS-mediated damage, with its function being to regulate oxidative stress responses. Under physiological conditions, Nrf2 activation has been observed to induce the expression of antioxidant enzymes, including HO-1, thereby facilitating the restoration of redox homeostasis [50]. However, it has been demonstrated that excessive ROS production following radiation exposure may overwhelm this regulatory axis, leading to sustained oxidative damage and subsequent activation of pro-inflammatory pathways. In this context, failure of adequate Nrf2-mediated compensation may facilitate NF-κB activation, thereby linking oxidative stress to inflammatory amplification. The presence of inflammatory cell infiltration, which was detected at higher levels in the G1 (14) and G2 (14) groups, similar to the TOS and OSI levels, indicates that inflammation reached its peak on the 14th day after RT. Mast cells represent a pivotal component in this process. The activation of these cells is initiated by an increased level of ROS following RT is known to activate nuclear factor-κB (NF-κB)–dependent inflammatory signaling, which promotes mast cell activation and degranulation [51]. NF-κB activation promotes the transcription of proinflammatory cytokines and enhances mast cell degranulation, thereby intensifying the inflammatory microenvironment. In the present study, significant increases in the mast cell count and degranulation rate were observed in the G1 and G2 groups. The elevated number of active degranulated mast cells observed in the G1 (28) group than in the G1 (14) group is indicative of ongoing oxidative stress [52]. The release of inflammatory mediators, such as TNF-α, IL-6, IL-1ß and TGF-β, is promoted by ROS-induced mast cell degranulation. This cascade establishes a mechanistic bridge between oxidative stress, cytokine release, and progressive tissue remodeling. The biochemical findings revealed that TNF-α, IL-6, and IL-1ß levels were significantly greater in the G1 and G2 groups than in the control group, in parallel with findings related to oxidative stress and inflammation. Compared with those in the 28-day follow-up groups, the levels in the G1 (14) and G2 (14) groups were greater, and these elevated levels were associated with oxidative stress. This finding is consistent with the results of other studies, which demonstrated that oxidative stress and inflammation peaked during the 14-day follow-up period [27]. In the context of these mediators, TGF-β1 assumes a pivotal role in the process of radiation-induced fibrosis. This is achieved through the promotion of fibroblast differentiation into myofibroblasts, as well as the enhancement of extracellular matrix deposition [53]. Mast cells are recognized as a significant source of TGF-β1. Their degranulation following exposure to radiation contributes to the release of profibrotic mediators into the local tissue microenvironment [54]. Furthermore, elevated ROS levels have been shown to stimulate TGF-β1 expression, thus amplifying fibrotic signalling pathways. Thus, ROS-driven NF-κB activation and mast cell–derived TGF-β1 release converge to promote fibroblast activation, extracellular matrix accumulation, and progressive fibrosis. In the present study, comparable levels of TGF-β1 were observed in the G1 and G2 groups following irradiation, suggesting that radiation-induced mast cell activation and oxidative stress, rather than vehicle administration, were the primary drivers of TGF-β1 upregulation. Elevated levels of oxidative stress, an indicator of progressive damage, suggest that TGF-β1 levels also increase. The results of the present study indicate that the increase in the number of active mast cells in the G1 and G2 groups over 28 days is indicative of the release of TGF- β1 from mast cells, in addition to its binding to receptors on mast cells, thereby inducing degranulation [55]. Cytokines, such as TGF-β, which also act as chemotactic factors for mast cells, may indirectly increase angiogenesis alongside fibrosis following mast cell degranulation [56]. Although tissue hypoxia accompanying fibrosis allows for neovascularization to a certain extent, it is generally reported to lead to vascular loss [57]. Impaired vascularity, in conjunction with increased vasoactive cytokines, has been demonstrated to promote collagen accumulation within connective tissue. Research has indicated a decrease in vascularization and a disruption in neoangiogenesis, which consequently results in endothelial impairment, after irradiation [57]. The present study also revealed a significant decrease in vascularization in the G1 and G2 groups compared with the control group. However, when the 14-day and 28-day groups were compared, a slight increase in vascularization was observed on day 28. This finding suggests that, alongside increased fibrosis, there is limited neovascularization development. The microscopic and macroscopic changes observed in normal tissues following radiotherapy indicate a complex and multifactorial picture involving intertwined processes such as inflammation, angiogenesis, granulation tissue formation, re-epithelialization, fibroproliferation, and extracellular matrix remodeling. Despite the development of various pharmacological strategies to address this process, current treatments are unable to functionally reverse the cellular losses caused by radiation. While the skin attempts to repair the oxidative damage caused by radiation via endogenous antioxidant systems, this response may be insufficient in the face of chronic damage. The necessity of exogenous antioxidant replacement has been postulated [58]. The efficacy of antioxidant supplements in reducing radiation damage remains to be elucidated, with symptomatic treatments such as moisturizers and corticosteroid creams being the most prevalent methods currently employed [56]. RA, which was investigated in the present study for its protective effect against damage caused by radiotherapy to the skin, is a polyphenolic compound containing an aromatic ring. The radioprotective efficacy of RA has been demonstrated in various organs damaged by ionizing radiation exposure on the basis of its antioxidant capacity [13, 15]. The protective effect of RA against oxidative stress induced by ionizing radiation has been demonstrated in various studies [18]. In the present study, the effects of RA, which is a protective agent against RT, on oxidative stress and inflammation were examined. In the G3 (14) and G3 (28) groups, epidermal and dermal thickness, oxidative stress markers, and the inflammatory response approximated those of the control groups. When the follow-up days were compared, it was hypothesized that the greater epidermal and dermal thicknesses observed in the G3 (14) group were due to edema and damage to the collagen fibers. The finding that 8-OHdG labeling in the G3 group was significantly lower than that in the G1 and G2 groups indicates that RA suppresses oxidative DNA damage [13]. The elevated 8-OHdG labeling observed in the G3 (28) group suggests the persistence of progressive damage. At this juncture, the consideration of varying doses and applications may be potential options. Furthermore, the biochemical data are corroborated by a decline in TOS and OSI levels, accompanied by an increase in TAS levels [49]. The absence of substantial variations in oxidative stress parameters between the G3 (14) and G3 (28) groups may be attributable to the ongoing progression of damage concomitant with tissue repair in the G3 (28) group. The effect of RA on mast cell activity was also clearly reflected in the results. In the G3 groups, a significant decrease in the number of mast cells and the rate of degranulation was observed. This decrease was accompanied by a parallel reduction in the levels of inflammatory cytokines (TNF-α, IL-6, IL-1β, and TGF-β1). A comparison of the G3 (14) and G3 (28) groups revealed an increase in degranulated mast cell activity on day 28, accompanied by a decrease in the total mast cell count. This decline, concomitant with a concurrent decline in inflammation, suggests that RA exerts a suppressive effect on inflammation and the fibrotic process through mast cells [10]. Furthermore, the low expression of TGF-β1 in the G3 group lends support to the potential antifibrotic effect of RA through this cytokine [59]. In the context of vascularization, a decrease in vascular structures was observed in the G1 and G2 groups. However, a limited neovascularization response was noted in the 28-day group. This finding suggests that, in the presence of fibrotic areas, a restricted angiogenesis response does indeed develop for tissue remodeling [57]. In the groups treated with RA, the level of vascularization was found to approach that of the control group, indicating that RA has a supportive effect on neoangiogenesis [48]. By reducing oxidative stress and inflammatory mediator release, RA may indirectly limit mast cell degranulation and TGF-β1–mediated fibroblast activation. This integrated mechanism suggests that RA acts not only as a free radical scavenger but also as a regulator of redox-sensitive and inflammation-driven profibrotic signaling pathways, ultimately contributing to attenuation of tissue remodeling and fibrosis. In conclusion, this study demonstrated that inflammation develops in healthy skin tissue after RT becomes chronic through mast cell activation and oxidative stress, transforming into a fibrotic structure. Rosmarinic acid has been demonstrated to suppress this process, resulting in a significant reduction in both oxidative stress and the inflammatory response. Furthermore, it has been shown to support dermal remodeling through its antifibrotic effect. These findings lend support to the evaluation of RA as a potential therapeutic agent for radiation-induced skin damage. It is imperative to acknowledge the limitations of this study when interpreting the findings. First, the findings are based on an animal model, which may not fully reflect the clinical conditions observed in humans. Second, the evaluation of rosmarinic acid was limited to a single dose and route of administration, without considering a dose–response assessment. The outcomes of various experiments must be subjected to rigorous evaluation, taking into account the distinct routes of administration and doses employed. Because the follow-up period was limited to 28 days, the available information is constrained by the inability to discern effects that manifest variable results over an extended timeframe, such as chronic inflammation and fibrosis. Conclusion The present study revealed that tissue damage associated with radiotherapy is characterized by a complex structure comprising multiple pathophysiological processes, including inflammation, vascularization disorders, fibrosis, and mast cell activity. The findings of the present study demonstrate that radiation-induced skin injury progresses through temporally distinct but interconnected pathological phases. At day 14, tissue damage was predominantly characterized by increased oxidative stress, inflammatory cell infiltration, and mast cell activation, indicating an acute inflammatory response. By day 28, fibrotic remodeling became more pronounced, accompanied by altered vascularization and increased dermal collagen deposition, reflecting a transition toward chronic tissue changes. Rosmarinic acid administration attenuated these radiation-induced alterations at both time points. RA reduced oxidative stress and inflammatory parameters in the early phase and limited mast cell activation and fibrotic progression in the later phase. These findings suggest that RA exerts both antioxidant and anti-inflammatory effects and may modulate the transition from acute inflammation to chronic fibrosis in irradiated skin tissue. Collectively, these results indicate that RA exerts protective effects against radiation-induced skin injury in this experimental model. The decrease in vascularity and the fibrotic response observed after radiation was associated with an increase in dermal collagen structures and limited neoangiogenesis. RA has a substantial regulatory effect, particularly on mast cell activity and inflammation levels. The decrease in mast cell count and inflammation in the G3 (28) group lends further support to the hypothesis that the anti-inflammatory effect of RA is mediated through mast cells. The reduction in oxidative stress in the G3 group also demonstrated the antioxidant activity of RA. These findings indicate that RA may modulate key pathways involved in radiation-induced skin injury and warrant further investigation in future preclinical and clinical studies. Study Limitations It is imperative to acknowledge the limitations of this study when interpreting the findings. Firstly, it should be noted that the results are based on an experimental animal model, which may not fully replicate the complexity of clinical radiation-induced skin injury in humans. Despite the fact that this model facilitates controlled investigation of pathophysiological mechanisms, extrapolation to clinical practice should be undertaken with caution. Secondly, rosmarinic acid was evaluated at a single dose and via a single route of administration; therefore, potential dose–response relationships and alternative delivery strategies were not investigated. Thirdly, the experimental period was limited to 28 days, which may not fully capture long-term fibrotic remodelling and chronic radiation-induced alterations. Furthermore, the study principally relied on histopathological, immunofluorescence, and biochemical analyses. Future research may benefit from incorporating additional molecular and mechanistic approaches, such as gene expression profiling, Western blot analysis of fibrosis- and inflammation-related signalling pathways, oxidative stress pathway analyses, and functional skin assessments. Further research in the form of longitudinal studies and translational investigations would provide additional insights into the therapeutic potential and clinical applicability of rosmarinic acid. Acknowledgements The authors used language support tools (Grammarly®) to assist in language checks, grammar refinement, and style consistency during manuscript preparation. Abbreviations 8-Hydroxy-2′-Deoxyguanosine Maximum Dose Point Deoxyribonucleic Acid Hematoxylin and Eosin Interleukin-1beta Interleukin-6 Istanbul Medipol University Animal Experiment Local Ethics Committee Neutral Buffered Formalin Nuclear factor-κB Oxidative Stress Index Rosmarinic Acid Reactive Oxygen Species Radiotherapy Skin-Source Distance Total Antioxidant Status Transforming Growth Factor Beta-1 Tumor Necrosis Factor-Alpha Total Oxidant Status Semi-quantitative score Authors’ contributions B.Z.K.: Methodology, Investigation, Visualization, Validation, Writing —original draft preparation, review & editing. E.Ç.: Visualization, Validation, Methodology, Investigation, Conceptualization. E.M.G.: Investigation, Validation. H.B.: Investigation, Validation. S.A.: Methodology, Investigation, Validation. F.E.: Methodology, Investigation, Validation. Funding This study was produced from Betül Zehra Karip’s thesis (supervisor: Esra Çikler) and was supported by the Scientific Research Projects Grants Unit, University of Health Sciences, İstanbul, Türkiye [Grant No: 2023/64]. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. Declarations Ethics approval and consent to participate All experimental procedures involving animals were approved by the Institutional Animal Care and Use Committee of İstanbul Medipol University (Med-HADYEK) in accordance with its guidelines (Approval No: 27, Date: April 21, 2023). A total of 42 male Sprague–Dawley rats, aged 6–8 weeks, were obtained from the İstanbul Medipol University Experimental Animal Center (Meditam). Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.